Rufinamide is a new anti-epileptic drug used as adjunctive treatment of Lennox-Gastaut syndrome. The aim of the study was to give preliminary data about effectiveness and tolerability of rufinamide in a group of patients affected with Lennox-Gastaut syndrome and presenting with refractory seizures.
Titolo: | Risultati preliminari dell’utilizzo di rufinamide in add-on su un campione di soggetti affetti da Sindrome di Lennox-Gastaut. |
Autori: | |
Data di pubblicazione: | 2010 |
Rivista: | |
Abstract: | Rufinamide is a new anti-epileptic drug used as adjunctive treatment of Lennox-Gastaut syndrome. The aim of the study was to give preliminary data about effectiveness and tolerability of rufinamide in a group of patients affected with Lennox-Gastaut syndrome and presenting with refractory seizures. |
Handle: | http://hdl.handle.net/11570/1900287 |
Appare nelle tipologie: | 14.a.1 Articolo su rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.